Fate Therapeutics Shares Continuing Higher Fri., Up 12%; Stock Up Nearly 30% Over Last 3 Sessions; Amended 13G Filing From Redmile Tues. Afternoon Showed Raised Stake From ~1.4M Shares At End Of Last Qtr. To ~6.6M Shares, Or 12.6% Stake
Paul Quintaro